Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Bin Gu

2PUBLICATIONS

8CO-AUTHORS

Haematological tumoursHaematology

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Oct 17, 2022

CD19 chimeric antigen receptor T-cell therapy as a bridge therapy for allogeneic hematopoietic stem cell transplantation in patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia.

Zhenzhen Yao, Bin Gu, Yanming Zhang

|Jun 26, 2020

Allogeneic haematopoietic stem cell transplantation improves outcome of adults with relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia entering remission following CD19 chimeric antigen receptor T cells.

Bin Gu, Bing-Yu Shi, Xiang Zhang

Pageof 1

Frequent Collaborators

1 joint publications

Xiao Ma

1 joint publications

De-Pei Wu

1 joint publications

Feng Chen

1 joint publications

Shengli Xue

1 joint publications

Xiaowen Tang

1 joint publications

Yue Han

1 joint publications

Depei Wu

1 joint publications

Ying Wang

Frequent Collaborators

1 joint publications

Xiao Ma

1 joint publications

De-Pei Wu

1 joint publications

Feng Chen

1 joint publications

Shengli Xue

Top Related Videos

Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy

Published on : Dec 17, 2019

See more related videos

Top Related Videos

Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy

Published on : Dec 17, 2019

See more related videos